tiprankstipranks
Trending News
More News >
Dogwood Therapeutics Inc (DWTX)
:DWTX
US Market

Dogwood Therapeutics (DWTX) Financial Statements

Compare
217 Followers

Dogwood Therapeutics Financial Overview

Dogwood Therapeutics's market cap is currently $7.95M. The company's EPS TTM is $-11.165; its P/E ratio is ―; Dogwood Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -12.23M$ -5.45M$ -12.32M$ -15.64M$ -10.01M
EBITDA$ -12.25M$ -5.45M$ -12.32M$ -15.64M$ -10.01M
Net Income$ -12.35M$ -5.30M$ -12.25M$ -15.96M$ -10.35M
Balance Sheet
Cash & Short-Term Investments$ 14.85M$ 3.32M$ 7.03M$ 14.01M$ 29.80M
Total Assets$ 94.31M$ 4.17M$ 8.37M$ 15.78M$ 31.47M
Total Debt$ 15.59M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 737.71K$ -3.32M$ -7.03M$ -14.01M$ -29.80M
Total Liabilities$ 30.03M$ 358.55K$ 1.04M$ 1.28M$ 1.53M
Stockholders' Equity$ 64.28M$ 3.81M$ 7.33M$ 14.50M$ 29.94M
Cash Flow
Free Cash Flow$ -8.79M$ -4.87M$ -11.47M$ -15.69M$ -3.90M
Operating Cash Flow$ -8.79M$ -4.87M$ -11.47M$ -15.69M$ -3.90M
Investing Cash Flow$ 3.76M$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 16.70M$ 1.16M$ 4.49M$ -97.60K$ 33.38M
Currency in USD

Dogwood Therapeutics Earnings and Revenue History

Dogwood Therapeutics Debt to Assets

Dogwood Therapeutics Cash Flow

Dogwood Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis